Daniel Escuín

2.7k total citations · 1 hit paper
26 papers, 2.1k citations indexed

About

Daniel Escuín is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Daniel Escuín has authored 26 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 17 papers in Cancer Research and 13 papers in Oncology. Recurrent topics in Daniel Escuín's work include Cancer, Hypoxia, and Metabolism (6 papers), Cancer Treatment and Pharmacology (5 papers) and Cancer-related molecular mechanisms research (5 papers). Daniel Escuín is often cited by papers focused on Cancer, Hypoxia, and Metabolism (6 papers), Cancer Treatment and Pharmacology (5 papers) and Cancer-related molecular mechanisms research (5 papers). Daniel Escuín collaborates with scholars based in Spain, United States and New Zealand. Daniel Escuín's co-authors include Paraskevi Giannakakou, Jonathan W. Simons, Theresa LaVallee, Enrique Lerma, Nicola J. Mabjeesh, Hua Zhong, Margaret Willard, Victor S. Pribluda, Michelle S. Johnson and Glenn M. Swartz and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Cell and Cancer.

In The Last Decade

Daniel Escuín

26 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF

2003 610 citations Nicola J. Mabjeesh, Daniel Escuín et al. Cancer Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Escuín Spain	17	1.2k	980	671	489	240	26	2.1k
Nicholas M. Donin United States	13	1.3k 1.2×	723 0.7×	1.1k 1.7×	404 0.8×	215 0.9×	25	2.6k
Prudence A. E. Scott United Kingdom	20	1.8k 1.5×	934 1.0×	885 1.3×	305 0.6×	142 0.6×	27	2.3k
Theresa LaVallee United States	22	1.4k 1.2×	745 0.8×	722 1.1×	275 0.6×	239 1.0×	57	2.4k
Rhonda L. Bitting United States	18	747 0.6×	731 0.7×	878 1.3×	930 1.9×	125 0.5×	62	2.0k
Reet Koomägi Germany	25	1.3k 1.1×	675 0.7×	766 1.1×	385 0.8×	157 0.7×	59	2.0k
Jeffrey Kiefer United States	24	1.2k 1.0×	513 0.5×	588 0.9×	268 0.5×	149 0.6×	60	2.0k
Klaus‐Jürgen Winzer Germany	16	1.1k 1.0×	570 0.6×	739 1.1×	212 0.4×	188 0.8×	47	2.0k
Sebastian Oltean United Kingdom	25	2.0k 1.7×	753 0.8×	733 1.1×	454 0.9×	153 0.6×	50	2.8k
H. Peter Rodemann Germany	29	1.8k 1.5×	560 0.6×	979 1.5×	663 1.4×	216 0.9×	56	3.0k
Bisrat G. Debeb United States	28	1.3k 1.2×	810 0.8×	1.1k 1.7×	310 0.6×	144 0.6×	61	2.3k

Countries citing papers authored by Daniel Escuín

Since Specialization

Citations

This map shows the geographic impact of Daniel Escuín's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Escuín with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Escuín more than expected).

Fields of papers citing papers by Daniel Escuín

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Escuín. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Escuín. The network helps show where Daniel Escuín may publish in the future.

Co-authorship network of co-authors of Daniel Escuín

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Escuín. A scholar is included among the top collaborators of Daniel Escuín based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Escuín. Daniel Escuín is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Escuín, Daniel, et al.. (2024). Small Non-Coding RNAs and Their Role in Locoregional Metastasis and Outcomes in Early-Stage Breast Cancer Patients. International Journal of Molecular Sciences. 25(7). 3982–3982. 4 indexed citations

Escuín, Daniel, et al.. (2023). Circulating miRNA Expression Is Inversely Correlated with Tumor Tissue or Sentinel Lymph Nodes in Estrogen Receptor-Positive Early Breast Cancer Patients. International Journal of Molecular Sciences. 24(17). 13293–13293. 2 indexed citations

Escuín, Daniel, Laura López-Vilaró, Josefina Móra, et al.. (2021). Circulating microRNAs in Early Breast Cancer Patients and Its Association With Lymph Node Metastases. Frontiers in Oncology. 11. 627811–627811. 19 indexed citations

Escuín, Daniel, Laura López-Vilaró, Josefina Móra, et al.. (2020). MicroRNA-1291 Is Associated With Locoregional Metastases in Patients With Early-Stage Breast Cancer. Frontiers in Genetics. 11. 562114–562114. 9 indexed citations

Gonzalo‐Calvo, David de, Laura López-Vilaró, Laura Nasarre, et al.. (2015). Intratumor cholesteryl ester accumulation is associated with human breast cancer proliferation and aggressive potential: a molecular and clinicopathological study. BMC Cancer. 15(1). 460–460. 177 indexed citations

Tibau, Ariadna, Laura López-Vilaró, Maitane Pérez-Olabarría, et al.. (2014). Chromosome 17 Centromere Duplication and Responsiveness to Anthracycline-Based Neoadjuvant Chemotherapy in Breast Cancer. Neoplasia. 16(10). 861–867. 12 indexed citations

Peiró, Gloria, Fernando Ortiz-Martínez, Alberto Gallardo, et al.. (2014). Src, a potential target for overcoming trastuzumab resistance in HER2-positive breast carcinoma. British Journal of Cancer. 111(4). 689–695. 72 indexed citations

Castellana, Bárbara, Daniel Escuín, Gloria Peiró, et al.. (2012). ASPN and GJB2 Are Implicated in the Mechanisms of Invasion of Ductal Breast Carcinomas. Journal of Cancer. 3. 175–183. 66 indexed citations

Carbonaro, Marisa, Daniel Escuín, Aurora O’Brate, Maria Thadani‐Mulero, & Paraskevi Giannakakou. (2012). Microtubules Regulate Hypoxia-inducible Factor-1α Protein Trafficking and Activity. Journal of Biological Chemistry. 287(15). 11859–11869. 61 indexed citations

10.

Gallardo, Alberto, Enrique Lerma, Daniel Escuín, et al.. (2012). Increased signalling of EGFR and IGF1R, and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas. British Journal of Cancer. 106(8). 1367–1373. 188 indexed citations

11.

Castellana, Bárbara, Daniel Escuín, Maitane Pérez-Olabarría, et al.. (2012). Genetic up-regulation and overexpression of PLEKHA7 differentiates invasive lobular carcinomas from invasive ductal carcinomas. Human Pathology. 43(11). 1902–1909. 12 indexed citations

12.

Darshan, Medha S., Matthew S. Loftus, Maria Thadani‐Mulero, et al.. (2011). Taxane-Induced Blockade to Nuclear Accumulation of the Androgen Receptor Predicts Clinical Responses in Metastatic Prostate Cancer. Cancer Research. 71(18). 6019–6029. 343 indexed citations

13.

Kanakkanthara, Arun, Anja Wilmes, Aurora O’Brate, et al.. (2011). Peloruside- and Laulimalide-Resistant Human Ovarian Carcinoma Cells Have βI-Tubulin Mutations and Altered Expression of βII- and βIII-Tubulin Isotypes. Molecular Cancer Therapeutics. 10(8). 1419–1429. 33 indexed citations

14.

Montserrat, Núria, Alberto Gallardo, Daniel Escuín, et al.. (2010). Repression of E-cadherin by SNAIL, ZEB1, and TWIST in invasive ductal carcinomas of the breast: a cooperative effort?. Human Pathology. 42(1). 103–110. 73 indexed citations

15.

Escuín, Daniel, Peter Burke, Todd Hembrough, et al.. (2009). The hematopoietic-specific β1-tubulin is naturally resistant to 2-Methoxyestradiol and protects patients from drug-induced myelosuppression. Cell Cycle. 8(23). 3914–3924. 17 indexed citations

16.

Mun, Ji-Young, Yuefang Wang, Ronald J. Voll, et al.. (2008). Syntheses and biological activities of novel 2-methoxyestradiol analogs, 2-fluoroethoxyestradiol and 2-fluoropropanoxyestradiol, and a radiosynthesis of 2-[18F]fluoroethoxyestradiol for positron emission tomography. Nuclear Medicine and Biology. 35(5). 615–622. 4 indexed citations

17.

Escuín, Daniel, Jonathan W. Simons, & Paraskevi Giannakakou. (2004). Exploitation of the HIF axis for cancer therapy. Cancer Biology & Therapy. 3(7). 608–611. 26 indexed citations

18.

Mabjeesh, Nicola J., Daniel Escuín, Theresa LaVallee, et al.. (2003). 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell. 3(4). 363–375. 610 indexed citations breakdown →

19.

Ramírez, José Luis, Carme Sarries, Bárbara Roig, et al.. (2003). Methylation patterns and K-ras mutations in tumor and paired serum of resected non-small-cell lung cancer patients. Cancer Letters. 193(2). 207–216. 98 indexed citations

20.

Escuín, Daniel & Rafael Rosell. (1999). The Anti-Apoptosis Survivin Gene and its Role in Human Cancer: An Overview. Clinical Lung Cancer. 1(2). 138–143. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact